For: | Popovic LS, Matovina-Brko G, Popovic M, Popovic M, Cvetanovic A, Nikolic I, Kukic B, Petrovic D. Immunotherapy in the treatment of lymphoma. World J Stem Cells 2021; 13(6): 503-520 [PMID: 34249225 DOI: 10.4252/wjsc.v13.i6.503] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v13/i6/503.htm |
Number | Citing Articles |
1 |
Antonio Cigliola, Gagan Prakash, Roger Li, Karima Oualla, Shilpa Gupta, Ashish M. Kamat, Jad Chahoud, Andrea Necchi, Philippe E. Spiess. Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions. Current Oncology Reports 2024; doi: 10.1007/s11912-024-01554-1
|
2 |
М. Р. Матущак, Г. Л. Панфілова. Pharmaceutical assessment of the rationale of the application of chemotherapy schemes containing immunotherapeutic drugs in the treatment of classical Hodgkin's lymphoma. Farmatsevtychnyi zhurnal 2023; (3): 68 doi: 10.32352/0367-3057.3.23.07
|
3 |
|
4 |
Sharina C Macapagal, Hayoung Lee, Javaria Abdul Jabbar, Anna Caroline Fjorden, Irene Tresa Joseph, Ramanpreet Kaur, Jihan A Mostafa. Efficacy of Brentuximab Vedotin and Nivolumab in Refractory or Relapsed Hodgkin Lymphoma: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.23452
|